Olympus Corporation: Study Results Show Long-term Efficacy o

Abstract of Durability Study Results for iTind Procedure Presented at 2022 American Urological Association Annual Meeting CENTER VALLEY, Pa. and HAMBURG, Germany, May 18, 2022 /PRNewswire/

Related Keywords

Germany , Italy , Hamburg , United States , American , Vanessa Malka , Francesco Porpiglia , Urol Nephrol , Urology Care Foundation , University Of Turin , Urology Division At San Luigi Gonzaga Hospital , American Urological Association Annual Meeting , Tind Commercial Head For Olympus Corporation , Olympus Corporation , International Prostate Symptom Score , Durability Study Results , Tind Procedure Presented , Urological Association Annual Meeting , Professor Francesco Porpiglia , Urology Division , San Luigi Gonzaga Hospital , Executive Director , Tind Commercial Head , International Multicenter Prospective Study , Temporary Implantable Nitinol Device , Lower Urinary Tract Symptoms , Benign Prostatic Hyperplasia , Updated September , Eurology Care , Accessed November , Tind Temporarily Implanted Nitinol Device , Lower Urinary Tract Symptoms Secondary , Controlled Trial , Olympus , Corporation , Study , Results , Show , Song , Term , Efficacy , Vstind , Procedure ,